海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
261件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Phase IIa Safety study of oral administration of anti-CD3 monoclonal antibody in non-responder genotype-I chronic Hepatitis C subjects, a single-blind, randomized, controlled multi-center study
- in non-responder genotype-I chronic Hepatitis C subjects MedDRA version: 14.0 Level: LLT Classification code 10047457 Term: Viral hepatitis C System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.0 Level: LLT Classification code 10008912 Term: Chronic hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Austria, Poland
- 2011-06-30
Recruiting
- Global cross-sectional burden-of-illness study in adolescent and adult patients with atopic dermatitis (MEASURE-AD)
- ;L20-L30 - Dermatitis and eczema
- Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Kuwait, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Saudi Arabia, Slovakia, Spain, Switzerland, Taiwan, Province of China, Turkey, United Arab Emirates
- 2020-01-21
Not recruiting
- Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Austria, Belgium, Bulgaria, Germany, Netherlands, Romania, South Africa
- 2013-02-05
Not recruiting
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
- Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Czechia, Ecuador, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan, Turkey, Ukraine, United States
- 2012-10-15
Not recruiting
- Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis;Atopic Dermatitis
- Australia, Canada, Germany, Hungary, New Zealand, United States
- 2015-07-29
Not Recruiting
- Phase 2 Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults with Atopic Dermatitis
- Atopic Dermatitis MedDRA version: 18.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Australia, Canada, Germany, Hungary, New Zealand, United States
- 2015-06-15
Not Recruiting
- Diacerein for the treatment of atopic dermatitis
- Atopic dermatitis;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria
- 2015-01-13
Not Recruiting
- EFFICACY AND LONG TERM SAFETY STUDY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE0-TO-SEVERE ATOPIC DERMATITIS.
- Moderate to severe atopic dermatitis (AD). MedDRA version: 18.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Australia, Belgium, Canada, Croatia, Czech Republic, France, Germany, Guadeloupe, Hungary, Italy, Japan, Korea, Republic of, Latvia, Netherlands, New Zealand, Poland, Romania, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom, United States
- 2014-03-06
Not Recruiting
- A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
- moderate to severe atopic dermatitis MedDRA version: 16.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Austria, Germany, Netherlands
- 2011-10-20
Recruiting
- A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
- Atopic Dermatitis
- Argentina, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Swaziland, Switzerland, Taiwan
- 2017-11-03
